Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Omega-3 fatty acids for bipolar disorder
Your Article Summary
A Cannabinoid CB1 Receptor Antagonist Ameliorates Impairment of Recognition Memory on Withdrawal from MDMA
Neuropsychopharmacology, 10/29/09
Nawata Y et al. – The impairment of recognition memory during withdrawal from MDMA may result from the activation of cannabinoid CB1 receptors in the hippocampus.
Related Articles
A comparison of two fMRI methods for predicting verbal memory decline after left temporal lobectomy: Language lateralization versus hippocampal activation asymmetry
Epilepsia, 10/13/09
Relevance Score: 91%
Phenotypic and functional characterization of switch memory B cells from patients with oligoarticular juvenile idiopathic arthritis
Arthritis Research & Therapy, 10/06/09
Relevance Score: 91%
Development of IgM memory to both a T cell-independent and a T cell-dependent antigen following infection with Vibrio cholerae O1 in Bangladesh
Infection and Immunity, 10/29/09
Relevance Score: 89%
Accuracy and perspective in involuntary autobiographical memory
Applied Cognitive Psychology, 10/06/09
Relevance Score: 89%
Self-esteem memories and school success in early adolescence
Applied Cognitive Psychology, 10/01/09
Relevance Score: 89%
Today in Basic Science...keeping you current
Receive free subspecialty "5-minute updates" via email
Acute Stress Impairs Hippocampal Mossy Fiber-CA3 Long-Term Potentiation by Enhancing cAMP-Specific Phosphodiesterase 4 Activity
Neuropsychopharmacology, 03/19/10
Long circulating nanoparticles of etoposide using PLGA-MPEG and PLGA-pluronic block copolymers: characterization, drug-release, blood-clearance, and biodistribution studies
Drug Development Research, 03/18/10
Biotransformation of prasugrel, a novel thienopyridine antiplatelet agent, to the pharmacologically active metabolite
Drug Metabolism and Disposition, 03/17/10
Today in Neuro/Psych pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Efficacy and tolerability of rasagiline in daily clinical use – a post-marketing observational study in patients with Parkinsons disease
European Journal of Neurology, 03/21/10
Olanzapine versus other atypical antipsychotics for schizophrenia
Cochrane Reviews, 03/19/10
Weight Gain and Insulin Resistance in Children Treated With Valproate: The Influence of Time
Journal of Child Neurology, 03/19/10
Article Search
Sponsor
Sponsor


See Latest Articles


